A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67

Annals of Oncology ◽

10.1093/annonc/mdp244 ◽

2009 ◽

Vol 20 (12) ◽

pp. 1971-1976 ◽

Author(s):

N.M. Hahn ◽

R.T. Zon ◽

M. Yu ◽

F.O. Ademuyiwa ◽

T. Jones ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Oncology Group ◽

Second Line Chemotherapy ◽

Castrate Resistant Prostate Cancer ◽

Castrate Resistant ◽

Line Chemotherapy

Download Full-text

A randomized phase II study comparing cabazitaxel/prednisone to cabazitaxel alone for second-line chemotherapy in men with metastatic castrate resistant prostate cancer (mCRPC): CABACARE

Annals of Oncology ◽

10.1093/annonc/mdx370.058 ◽

2017 ◽

Vol 28 ◽

pp. v292-v293 ◽

Author(s):

C. Buonerba ◽

D. Bosso ◽

S. De Placido ◽

G. Di Lorenzo

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Second Line Chemotherapy ◽

Randomized Phase Ii ◽

Castrate Resistant Prostate Cancer ◽

Castrate Resistant ◽

Line Chemotherapy

Download Full-text

A multicenter phase II study of pemetrexed as second-line chemotherapy for the treatment of hormone refractory prostate cancer (HRPC); Hoosier Oncology Group GU-0367

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.16019 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 16019-16019 ◽

Author(s):

N. M. Hahn ◽

R. T. Zon ◽

T. Jones ◽

F. Ademuyiwa ◽

W. M. Dugan ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Second Line ◽

Oncology Group ◽

Second Line Chemotherapy ◽

Multicenter Phase ◽

Hormone Refractory ◽

Line Chemotherapy

Download Full-text

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.03.043 ◽

2006 ◽

Vol 103 (2) ◽

pp. 523-526 ◽

Author(s):

Paula M. Fracasso ◽

John A. Blessing ◽

Kelly L. Molpus ◽

Lisa M. Adler ◽

Joel I. Sorosky ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Second Line ◽

Oncology Group ◽

Oncology Group Study ◽

Second Line Chemotherapy ◽

Line Chemotherapy

Download Full-text

Pemetrexed as second-line chemotherapy for castration-resistant prostate cancer after docetaxel failure: Results from a phase II study

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2010.11.012 ◽

2013 ◽

Vol 31 (2) ◽

pp. 180-186 ◽

Author(s):

Orazio Caffo ◽

Lucia Fratino ◽

Roberto Barbieri ◽

Alessandra Perin ◽

Thomas Martini ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Chemotherapy ◽

Castration Resistant ◽

Line Chemotherapy

Download Full-text

Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.03.009 ◽

2008 ◽

Vol 110 (1) ◽

pp. 65-70 ◽

Author(s):

David Scott Miller ◽

John A. Blessing ◽

Diane C. Bodurka ◽

Albert J. Bonebrake ◽

John O. Schorge

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Second Line ◽

Oncology Group ◽

Second Line Chemotherapy ◽

Recurrent Carcinoma ◽

Line Chemotherapy

Download Full-text

A Prognostic Model for Predicting Radiographic Progression- Free Survival (Rpfs) in Metastatic Castrate-Resistant Prostate Cancer Men Treated with Second-Line Chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdu336.43 ◽

2014 ◽

Vol 25 ◽

pp. iv276

Author(s):

S. Halabi ◽

H. Zhou ◽

E.J. Small ◽

N.C. Solomon ◽

A.J. Armstrong ◽

...

Keyword(s):

Prostate Cancer ◽

Prognostic Model ◽

Radiographic Progression ◽

Progression Free Survival ◽

Second Line ◽

Free Survival ◽

Second Line Chemotherapy ◽

Castrate Resistant Prostate Cancer ◽

Castrate Resistant ◽

Line Chemotherapy

Download Full-text

Faculty Opinions recommendation of Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120032.576156 ◽

2008 ◽

Author(s):

Enrico Sartori

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Second Line ◽

Oncology Group ◽

Second Line Chemotherapy ◽

Recurrent Carcinoma ◽

Line Chemotherapy

Download Full-text

PCN17 Chemotherapy Treatment and Impact of Second Line Chemotherapy on Overall Survival (OS) in Metastatic Castrate Resistant Prostate Cancer (CRPC) in Southeastern Oncology Community Practice

Value in Health ◽

10.1016/j.jval.2012.03.1135 ◽

2012 ◽

Vol 15 (4) ◽

pp. A210

Author(s):

B. Seal ◽

S.D. Sullivan ◽

S. Ramsey ◽

C. Kreilick ◽

S. Foltz-Boklage ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Community Practice ◽

Second Line ◽

Chemotherapy Treatment ◽

Second Line Chemotherapy ◽

Castrate Resistant Prostate Cancer ◽

Castrate Resistant ◽

Line Chemotherapy

Download Full-text

Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: A phase II study

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/j.1743-7563.2012.01554.x ◽

2012 ◽

Vol 9 (1) ◽

pp. 60-65 ◽

Author(s):

Amal Halim ◽

Niveen Abotouk

Keyword(s):

Transitional Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Transitional Cell ◽

Second Line ◽

Second Line Chemotherapy ◽

Carcinoma Of The Bladder ◽

Line Chemotherapy

Download Full-text

FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1875-1 ◽

2012 ◽

Vol 69 (6) ◽

pp. 1641-1645 ◽

Author(s):

Alberto Zaniboni ◽

Enrico Aitini ◽

Sandro Barni ◽

Daris Ferrari ◽

Stefano Cascinu ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Pancreatic Cancer ◽

Second Line ◽

Second Line Chemotherapy ◽

Multicenter Phase ◽

Line Chemotherapy

Download Full-text